1. Home
  2. INLX vs ASRT Comparison

INLX vs ASRT Comparison

Compare INLX & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • ASRT
  • Stock Information
  • Founded
  • INLX 1996
  • ASRT 1995
  • Country
  • INLX United States
  • ASRT United States
  • Employees
  • INLX N/A
  • ASRT N/A
  • Industry
  • INLX EDP Services
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • ASRT Health Care
  • Exchange
  • INLX Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • INLX 53.5M
  • ASRT 57.9M
  • IPO Year
  • INLX N/A
  • ASRT 1997
  • Fundamental
  • Price
  • INLX $12.05
  • ASRT $0.71
  • Analyst Decision
  • INLX
  • ASRT Strong Buy
  • Analyst Count
  • INLX 0
  • ASRT 1
  • Target Price
  • INLX N/A
  • ASRT $3.50
  • AVG Volume (30 Days)
  • INLX 1.9K
  • ASRT 236.4K
  • Earning Date
  • INLX 08-12-2025
  • ASRT 08-11-2025
  • Dividend Yield
  • INLX N/A
  • ASRT N/A
  • EPS Growth
  • INLX N/A
  • ASRT N/A
  • EPS
  • INLX N/A
  • ASRT N/A
  • Revenue
  • INLX $17,758,634.00
  • ASRT $119,001,000.00
  • Revenue This Year
  • INLX $2.47
  • ASRT N/A
  • Revenue Next Year
  • INLX $7.72
  • ASRT $11.91
  • P/E Ratio
  • INLX N/A
  • ASRT N/A
  • Revenue Growth
  • INLX 3.21
  • ASRT N/A
  • 52 Week Low
  • INLX $7.75
  • ASRT $0.51
  • 52 Week High
  • INLX $16.50
  • ASRT $1.40
  • Technical
  • Relative Strength Index (RSI)
  • INLX 40.87
  • ASRT 53.99
  • Support Level
  • INLX $12.95
  • ASRT $0.66
  • Resistance Level
  • INLX $13.66
  • ASRT $0.79
  • Average True Range (ATR)
  • INLX 0.46
  • ASRT 0.03
  • MACD
  • INLX -0.18
  • ASRT -0.00
  • Stochastic Oscillator
  • INLX 0.00
  • ASRT 40.38

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: